TherapeuticsMD, Inc. (TXMD) Capital expenditures 2013–2022
TherapeuticsMD, Inc. (TXMD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$34,000FY2022 · since FY2013: $66,405 → $34,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $34,000 | -83.6% |
| FY2021 | $207,000 | -91.6% |
| FY2020 | $2.5M | +1028.8% |
| FY2019 | $217,040 | +251.1% |
| FY2018 | $61,817 | -84.4% |
| FY2017 | $396,154 | +139.7% |
| FY2016 | $165,257 | +433.7% |
| FY2015 | $30,962 | -24.1% |
| FY2014 | $40,790 | -38.6% |
| FY2013 | $66,405 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice